Succinate puts the brakes on de novo purine synthesis
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.10.020 ↗Kurz gefasst
Kommentar in der Zeitschrift Molecular Cell, 2025. Verfasst von Timothy C Kenny und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: Purines, Succinic Acid, Succinate Dehydrogenase, Neoplasms. Die Arbeit nennt 7 Literaturangaben. Gefördert von: Innovation Fund, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Abstract (Originalsprache)
In this issue of Molecular Cell, Nengroo et al.1 report that the tricarboxylic acid (TCA) cycle enzyme succinate dehydrogenase (SDH) is essential for de novo purine synthesis, revealing a previously unrecognized metabolic dependency in cancer that can be leveraged therapeutically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
- Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA. Electronic address: kbirsoy@rockefeller.edu.
Förderung
- Innovation Fund
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- Mark Foundation For Cancer Research
- National Cancer Institute
Zitieren
APA
Kenny, T. C., & Birsoy, K. (2025). Succinate puts the brakes on de novo purine synthesis. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.10.020
Vancouver
Kenny TC, Birsoy K. Succinate puts the brakes on de novo purine synthesis. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.10.020
BibTeX
@article{Kenny2025,
author = {Kenny, Timothy C and Birsoy, Kıvanç},
title = {Succinate puts the brakes on de novo purine synthesis},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.10.020}
}
EUVIMED